During the first days of mammalian development, the embryo forms the blastocyst, the structure responsible for implanting the mammalian embryo. Consisting of an epithelium enveloping the pluripotent inner cell mass and a fluid-filled lumen, the blastocyst results from a series of cleavage divisions, morphogenetic movements, and lineage specification. Recent studies have identified the essential role of actomyosin contractility in driving cytokinesis, morphogenesis, and fate specification, leading to the formation of the blastocyst. However, the preimplantation development of contractility mutants has not been characterized. Here, we generated single and double maternal-zygotic mutants of non-muscle myosin II heavy chains (NMHCs) to characterize them with multiscale imaging. We found that Myh9 (NMHC II-A) is the major NMHC during preimplantation development as its maternal-zygotic loss causes failed cytokinesis, increased duration of the cell cycle, weaker embryo compaction, and reduced differentiation, whereas Myh10 (NMHC II-B) maternal-zygotic loss is much less severe. Double maternal-zygotic mutants for Myh9 and Myh10 show a much stronger phenotype, failing most of the attempts of cytokinesis. We found that morphogenesis and fate specification are affected but nevertheless carry on in a timely fashion, regardless of the impact of the mutations on cell number. Strikingly, even when all cell divisions fail, the resulting single-celled embryo can initiate trophectoderm differentiation and lumen formation by accumulating fluid in increasingly large vacuoles. Therefore, contractility mutants reveal that fluid accumulation is a cell-autonomous process and that the preimplantation program carries on independently of successful cell division.
During embryonic development, cells execute their genetic program to build organisms with the correct cell fate, shape, position, and number. In this process, the coordination between cell proliferation, differentiation, and morphogenesis is crucial. In mice, the early blastocyst initially consists of 32 cells distributed among the trophectoderm (TE) and inner cell mass (ICM), with squamous TE cells enveloping the ICM and a lumen called the blastocoel (Frankenberg et al., 2016; Płusa and Piliszek, 2020; Rossant, 2016). Starting from the zygote, the early blastocyst forms after five cleavage divisions, three morphogenetic movements, and two lineage commitments (Maître, 2017; White et al., 2018; Zhang and Hiiragi, 2018). Differentiation and morphogenesis are coupled by the formation of a domain of apical material after the third cleavage (Ziomek and Johnson, 1980). The apical domain promotes differentiation into TE by counteracting signals from cell-cell contacts, which control the nuclear localization of the co-transcriptional activator Yap (Hirate et al., 2013; Nishioka et al., 2009; Wicklow et al., 2014). The apical domain also guides cell division orientation (Dard et al., 2009; Korotkevich et al., 2017; Niwayama et al., 2019) and contact rearrangements (Maître et al., 2016), which is key for positioning cells at the embryo surface or interior. Morphogenesis and cleavages are concomitant and appear synchronized with compaction starting after the third cleavage, internalization after the fourth, and lumen opening after the fifth. Beyond this apparent coordination, the existence of a coupling between cleavages and morphogenesis requires further investigations.
Actomyosin contractility is a conserved instrument driving animal morphogenesis (Heisenberg and Bellaïche, 2013; Lecuit and Yap, 2015) and cytokinesis (Ramkumar and Baum, 2016). Recent studies have suggested key contributions of actomyosin contractility during all the morphogenetic steps leading to the formation of the blastocyst (Özgüç and Maître, 2020). During the 8-cell stage, increased contractility at the cell-medium interface pulls blastomeres together and compacts the embryo (Maître et al., 2015). Also, cells form an apical domain that inhibits actomyosin contractility (Maître et al., 2016; Zhu et al., 2017). During the fourth cleavage, the asymmetric inheritance of this domain leads sister cells to exhibit distinct contractility (Anani et al., 2014; Maître et al., 2016). This causes the most contractile blastomeres to internalize and adopt ICM fate, while weakly contractile cells are stretched at the surface of the embryo and become TE (Maître et al., 2016; Samarage et al., 2015). When the blastocoel fluid starts to accumulate, these differences in contractility between ICM and TE cells guide the fluid away from ICM-ICM cell-cell contacts (Dumortier et al., 2019). Finally, contractility has been proposed to control the size of the blastocoel negatively by increasing the tension of the TE and positively by reinforcing cell-cell adhesion via mechanosensing (Chan et al., 2019). Together, these findings highlight actomyosin as a major engine powering blastocyst morphogenesis.
To change the shape of animal cells, myosin motor proteins contract a network of cross-linked actin filaments, which can be tethered to the plasma membrane, adherens junctions, and/or focal adhesions (Murrell et al., 2015). This generates tension, which cells use to change shape and tissue topology (Clark et al., 2013; Salbreux et al., 2012). Among myosin motors, non-muscle myosin II are the key drivers of cell shape changes (Zaidel-Bar et al., 2015). Non-muscle myosin II complexes assemble from myosin regulatory light chains, myosin essential light chains, and non-muscle myosin heavy chains (NMHCs) (Vicente-Manzanares et al., 2009). NMHCs are responsible for generating the power stroke and exist in three distinct paralogs in mice and humans: NMHC II-A, II-B, and II-C, encoded by the genes Myh9/MYH9, Myh10/MYH10, and Myh14/MYH14 (Conti et al., 2004). Distinct paralogs co-assemble into the same myosin mini-filaments (Beach et al., 2014) and, to some extent, seem to have redundant actions within the cells. However, several in vitro studies point to specific roles of NMHC paralogs. For example, MYH9 plays a key role in setting the speed of furrow ingression during cytokinesis (Taneja et al., 2020; Yamamoto et al., 2019) and is essential to drive bleb retraction (Taneja and Burnette, 2019). During cell-cell contact formation, MYH9 was found essential for cadherin adhesion molecule clustering and setting contact size while MYH10 would be involved in force transmissions across the junction and would influence contact rearrangements (Heuzé et al., 2019; Smutny et al., 2010).
These studies at the subcellular level and at a short timescale complement those at the organismal level and at a long timescale. In mice, the zygotic knockout of Myh14 causes no obvious phenotype with animals surviving to adulthood with no apparent defect (Ma et al., 2010), whereas the loss of either Myh9 (Conti et al., 2004) or Myh10 (Tullio et al., 1997) is embryonic lethal. Myh9 zygotic knockout embryos die at E7.5 due to visceral endoderm adhesion defects (Conti et al., 2004). Myh10 zygotic knockout mice die between E14.5 and P1 because of heart, brain, and liver defects (Tullio et al., 1997). In addition, knocking out both Myh10 and Myh14 can lead to abnormal cytokinesis (Ma et al., 2010). Elegant gene replacement experiments have also revealed insights into partial functional redundancy between Myh9 and Myh10 during development (Wang et al., 2010). However, despite the prominent role of actomyosin contractility during preimplantation development (Ma et al., 2010), the specific functions of NMHC paralogs remain largely unknown. Previous genetic studies have relied on zygotic knockouts (Conti et al., 2004; Ma et al., 2010; Tullio et al., 1997), which do not remove the maternally deposited mRNA and proteins of the deleted genes. This often hides the essential functions of genes during preimplantation morphogenesis, as is the case, for example, with the cell-cell adhesion molecule CDH1 (Stephenson et al., 2010). Moreover, NMHCs could have redundant functions, and gene deletions may trigger compensation mechanisms, which would obscure the function of essential genes (Rossi et al., 2015).
In this study, we generated maternal-zygotic deletions of single or double NMHC genes to investigate the molecular control of contractile forces during preimplantation development. We used nested time-lapse microscopy to quantitatively assess the effect of maternal-zygotic deletions at different timescales. This reveals the dominant role of MYH9 over MYH10 in generating the contractility that shapes the mouse blastocyst. In addition, double maternal-zygotic Myh9 and Myh10 knockout reveals compensatory mechanisms provided by MYH10 in generating enough contractility for cytokinesis when MYH9 is absent. Moreover, the maternal-zygotic knockout of both Myh9 and Myh10 can cause embryos to fail all five successive cleavages, resulting in syncytial single-celled embryos. These single-celled embryos nevertheless initiate lineage specification and blastocoel formation by accumulating fluid into intracellular vacuoles. Therefore, double maternal-zygotic NMHC mutants reveal that fluid accumulation in the blastocyst is a cell-autonomous process. Finally, we confirm this surprising finding by fusing all blastomeres of wild-type (WT) embryos, thereby forming single-celled embryos, which accumulate fluid into inflating vacuoles.
As in humans, the mouse genome contains three genes encoding NMHCs: Myh9, Myh10, and Myh14. To decipher the specific contributions of NMHC paralogs to preimplantation development, we first investigated the expression of Myh9, Myh10, and Myh14.
We performed real-time quantitative PCR (qPCR) at four different stages in order to cover the levels of transcripts at key steps of preimplantation development. We detected high levels of Myh9 mRNA throughout preimplantation development (Figure 1A). Importantly, transcripts of Myh9 are by far the most abundant among NMHCs at the zygote stage (E0.5), which suggests that Myh9 is the main NMHC paralog provided maternally. Myh10 mRNA is detected at very low levels in zygotes before it reaches comparable levels to Myh9 mRNA at the morula stage (Figure 1A). We found that Myh14 is not expressed during preimplantation stages (Figure 1A). Since Myh14 homozygous mutant mice are viable and show no apparent defects (Ma et al., 2010), Myh14 is unlikely to play an important role in preimplantation development. These qPCR measurements show similar trends to available mouse single cell RNA sequencing (scRNA-seq) data (Figure 1—figure supplement 1A; Deng et al., 2014). In humans, scRNA-seq data indicate similar expression levels between MYH9 and MYH10 during preimplantation development and, as in mice, the absence of MYH14 expression (Figure 1—figure supplement 1B; Yan et al., 2013). This points to a conserved regulation of NMHC paralogs in mouse and human preimplantation development.
At the protein level, immunostaining of MYH9 becomes visible at the cortex of blastomeres from the zygote stage onwards (Figure 1B). On the other hand, MYH10 becomes detectable at the earliest at the 16-cell stage (Figure 1B). Finally, we used transgenic mice expressing endogenously tagged MYH9-GFP to assess the relative parental contributions of MYH9 protein (Figure 1—figure supplement 1C–D). Embryos coming from MYH9-GFP females show highest levels of fluorescence at the zygote stage, consistent with our qPCR measurement and scRNA-seq data (Figure 1A, Figure 1—figure supplement 1A). MYH9-GFP produced from the paternal allele is detected at the 4-cell stage and increases until blastocyst stage, reaching levels comparable to blastocyst coming from MYH9-GFP females (Figure 1—figure supplement 1C–D).
Together, we conclude that MYH9 and MYH10 are the most abundant NMHCs during mouse and human preimplantation development and that MYH9 is heavily maternally provided at both the transcript and protein level in the mouse embryo (Figure 1, Figure 1—figure supplement 1).
Initial studies of Myh9 or Myh10 zygotic knockouts have reported that single zygotic knockouts are able to implant, suggesting they are able to form a functional blastocyst (Conti et al., 2004; Tullio et al., 1997). A potential lack of phenotype could be due to maternally provided products, which are most abundant in the case of Myh9 (Figure 1, Figure 1—figure supplement 1). To eliminate this contribution, we used Zp3Cre/+ mediated maternal deletion of conditional knockout alleles of Myh9 and Myh10. This generated either maternal-zygotic (mz) homozygous or maternal only (m) heterozygous knockout embryos for either Myh9 or Myh10. Embryos were recovered at E1.5, imaged throughout the rest of their preimplantation development, stained, and genotyped once WT embryos reached the blastocyst stage. We implemented a nested time-lapse protocol to image each embryo at the long (every 30 min for about 50 hr) and short (every 5 s for 10 min twice for each embryo around the time of their 8-cell stage) timescales. This imaging protocol allowed us to visualize the effect of actomyosin contractility at multiple timescales, as it is involved in pulsatile contractions, cytokinesis, and morphogenesis, which take place on timescales of tens of seconds, minutes, and hours, respectively (Maître et al., 2015; Maître et al., 2016).
The first visible phenotype concerns the zona pellucida (ZP), which encapsulates the preimplantation embryo. WT and maternal Myh10 mutants have a spherical ZP, whereas maternal Myh9 mutants show an irregularly shaped ZP (Figure 2—figure supplement 1A,B). This suggests a previously unreported role of contractility in the formation of the ZP during oogenesis that is mediated specifically by maternal MYH9. The abnormally shaped ZP could cause long-term deformation of the embryo, as previous studies indicate that the ZP can influence the shape of the embryo at the blastocyst stage (Kurotaki et al., 2007; Motosugi et al., 2005).
During compaction, angles formed at the surface of contacting cells increase as blastomeres are pulled into closer contact (Figure 2A). In WT embryos, contact angles increase from 87 ± 3° to 147 ± 2° during the 8-cell stage between the third and the fourth cleavage (mean ± SEM from the end of the last cleavage of the third wave to the first one of the fourth wave, 23 embryos, Figure 2A–B, Appendix 1—table 1–2, Figure 2—video 1), as measured previously (Maître et al., 2015; Zhu et al., 2017). In mzMyh9 embryos, contact angles only grow from 85 ± 2° to 125 ± 4° (mean ± SEM, 15 embryos, Figure 2A–B, Appendix 1—table 1–2). This reduced ability to compact is in agreement with previous measurements on heterozygous mMyh9 embryos, which generate a lower surface tension, and therefore cannot efficiently pull cells into closer contact (Maître et al., 2016). During the 8-cell stage, mzMyh10 embryos initially grow their contacts from 87 ± 5° to 121 ± 4°, similarly to mzMyh9 embryos (mean ± SEM, 11 embryos, Figure 2A–B, Appendix 1—table 1). However, unlike mzMyh9 embryos, mzMyh10 embryos continue to increase their contact size and reach compaction levels identical to WT embryos by the end of the 16-cell stage (148 ± 4°, mean ± SEM, 11 embryos, Figure 2A–B, Appendix 1—table 1). Importantly, heterozygous mMyh9 or mMyh10 embryos show similar phenotypes to their respective homozygous counterparts (Figure 2B, Appendix 1—table 1–2), suggesting that maternal loss dominates for both NMHC paralogs and that the paternal allele makes little difference. Together, we conclude that maternal MYH9 is essential for embryos to compact fully, whereas MYH10 only regulates the rate of compaction.
During the 8-cell stage, contractility becomes visible on the short timescale as periodic contractions, which we can use to gauge the specific contribution of NMHCs (Maître et al., 2015; Maître et al., 2016). We performed particle image velocimetry (PIV) and Fourier analysis to evaluate the period and amplitude of periodic movements (Figure 2D–F; Maître et al., 2015). While 14/21 WT embryos displayed periodic contractions, these were rarely detected in Myh9 mutants (1/15 mzMyh9 and 0/8 mMyh9 embryos) and occasionally in Myh10 mutants (3/11 mzMyh10 and 8/20 mMyh10 embryos; Figure 2G, Figure 2—video 2). This suggests that contractility is reduced after maternal loss of Myh10 and is greatly reduced following maternal loss of Myh9. This hierarchy in the phenotypes of the NMHC paralog mutants parallels the one observed on the long timescale during compaction (Figure 2B). In fact, we found that the amplitude of periodic contractions correlates with the contact angle across the genotypes we considered (Figure 2H, 78 embryos, Pearson’s R = 0.637, p < 10−5, Appendix 1—table 3). This analysis across timescales reveals the continuum between the short-term impact of Myh9 or Myh10 loss onto contractile movements and the long-term morphogenesis, as previously observed for internalizing ICM cells (Maître et al., 2016).
We also noted that the duration of the 8-cell stage is longer in embryos lacking maternal Myh9 (9.8 ± 0.5 hr from the third to the fourth wave of cleavages, mean ± SEM, 15 embryos) as compared to WT (7.0 ± 0.3 hr, mean ± SEM, 23 embryos; Figure 2A,B, Appendix 1—tables 1–2, Figure 2—video 1). This is not the case for the duration of the fourth wave of cleavages or the ensuing 16-cell stage, which are similar in these different genotypes (Appendix 1—table 2). On the long timescale, longer cell cycles could affect the number of cells in Myh9 mutants. Indeed, when reaching the blastocyst stage, mzMyh9 embryos count less than half the number of cells than WT (58.1 ± 2.9 cells in 23 WT embryos, as compared to 25.2 ± 2.8 cells in 15 mzMyh9 embryos, Mean ± SEM; Figure 3B). In the time-lapse movies, we did not observe cell death, which could, in principle, also explain a reduced cell number at the blastocyst stage. On the other hand, we did observe reverting cleavages in maternal Myh9 mutants (Figure 2—video 3), effectively reducing cell number at the blastocyst stage. Loss of MYH9 is likely to cause difficulties during cytokinesis (Taneja et al., 2020; Yamamoto et al., 2019), which could in turn impact cell cycle progression (Figure 2B) and explain the significant reduction in cell number in mzMyh9 embryos. As for mzMyh10 embryos, we do not observe any cell cycle delay and count blastocysts with the correct cell number (Figure 2B and Figure 3B), indicating that MYH9 is the primary NMHC powering cytokinesis during mouse preimplantation development.
The second morphogenetic movement consists in the positioning of cells on the inside of the embryo after the fourth cleavage division to form the first lineages of the mammalian embryo. To see if this process is affected in NMHC mutants, we counted the number of inner and outer cells on immunostaining at the blastocyst stage (Figure 3A–C). Despite showing less than half the expected cell number, mzMyh9 blastocysts show the same proportion of inner and outer cells as WT and mzMyh10 embryos (Figure 3C). This suggests that the remaining contractility is sufficient to drive cell internalization or that oriented cell divisions can mitigate the loss of contractility-mediated internalization (Korotkevich et al., 2017; Maître et al., 2016; Niwayama et al., 2019). Outer and inner cells differentiate into TE and ICM, respectively. To assess whether differentiation is affected in NMHC mutants, we performed immunostaining of TE marker CDX2 and ICM marker SOX2 at the blastocyst stage (Figure 3A; Avilion et al., 2003; Strumpf et al., 2005). mzMyh10 embryos display negligible reduction in CDX2 and SOX2 levels compared to WT embryos (Figure 3E–G). On the other hand, we found that mzMyh9 embryos show lower levels of CDX2 in their outer cells, as measured here and previously for mMyh9 embryos at the 16-cell stage (Figure 3F; Maître et al., 2016), and of SOX2 for inner cells compared to WT embryos (Figure 3G). This is caused in part by the presence of individual unspecified cells localized both inside and at the surface of mzMyh9 embryos (Figure 3D). To assess whether delayed cell cycle progression may explain the reduced differentiation, we calculated the correlation between the duration of the 8-cell stage and the levels of CDX2 in the TE and of SOX2 in the ICM. This correlation is poor for all maternal Myh9 mutants (Pearson’s R = −0.193 for CDX2 and −0.076 for SOX2, 22 embryos, p>10−2), which does not support reduced differentiation levels due to cell cycle delay.
To assess whether signalling upstream of CDX2 and SOX2 expression is affected in NMHC mutants, we stained embryos for the co-transcriptional activator YAP (Hirate et al., 2013; Nishioka et al., 2009; Royer et al., 2020; Wicklow et al., 2014). In WT embryos, YAP is enriched specifically in the nuclei of TE cells (Figure 3—figure supplement 1; Hirate et al., 2013; Nishioka et al., 2009; Wicklow et al., 2014). Consistent with CDX2 and SOX2 levels, YAP localization is unaffected in mzMyh10 mutants and reduced in mzMyh9 mutants (Figure 3—figure supplement 1), as observed previously in mMyh9 mutants at the 16-cell stage (Maître et al., 2016). In the mouse preimplantation embryo, the nuclear localization of YAP is promoted by signals from the apical domain (Hirate et al., 2013). ML7 treatment, which inhibits the myosin light chain kinase, suggests that contractility may be required for apical domain formation (Zhu et al., 2017). However, immunostaining of apico-basal markers reveals that, as in WT, mzMyh9 and mzMyh10 embryos accumulate the apical marker PRKCz at the embryo surface (Figure 4; Hirate et al., 2013). Also, basolateral markers such as the adhesion molecule CDH1 or members of the fluid transport machinery, such as the ATP1A1 subunit of the Na/K pump and aquaporin AQP3, are enriched at basolateral membranes of WT, mzMyh9, and mzMyh10 embryos alike (Figure 4; Barcroft et al., 2003; Barcroft et al., 2004; Dumortier et al., 2019; Stephenson et al., 2010). Together, these findings suggest that MYH9-mediated contractility is required for the correct expression of lineage markers downstream of YAP but dispensable for the establishment of apico-basal polarity.
Apico-basal polarity is essential for the final morphogenetic step shaping the blastocyst: the formation of the first mammalian lumen. After the fifth cleavage, the growth of the blastocoel inflates and increases the projected area of WT embryos steadily at 3.9 ± 0.5 µm2/min (mean ± SEM, 20 embryos; Figure 2C, Figure 2—video 1). During lumen formation, mzMyh9 and mzMyh10 embryos inflate at 3.9 ± 1.0 and 4.0 ± 0.5 µm2/min, respectively, which is similar to WT embryos (mean ± SEM, 9 and 7 embryos; Student’s t test compared to WT p>10−2, Figure 2C). This suggests that blastocoel expansion rate is unaffected in NMHC mutants. Importantly, we observe that the time of lumen opening in mzMyh9 embryos is not delayed compared to WT embryos (Figure 2A–C). In fact, relative to the time of third cleavage, the lumen inflates on average at an earlier stage in mzMyh9 embryos than in WT (Figure 2C). Some mzMyh9 embryos begin inflating their lumen before the fifth wave of cleavages (5/11; Figure 2—video 1), while all WT and mzMyh10 embryos begin lumen formation after the first cleavages of the fifth wave. This argues against mzMyh9 embryos having a global delay in their development, despite their longer cell cycles, lower cell number (Figure 2B and Figure 3B), and impaired differentiation (Figure 3D,F–G). Finally, when the lumen becomes sufficiently large, embryos come into contact with the ZP. 3D segmentation of blastocysts reveals that embryos with mutated maternal Myh9 alleles become less spherical than those with a WT allele (Figure 2—figure supplement 1C–F). In fact, the shape of the ZP of mutant embryos at the 2-cell stage correlates with the shape of embryos at the blastocyst stage (Figure 2—figure supplement 1G; 67 embryos from all genotypes combined but WT, Pearson’s R = −0.739, p<10−2), which suggests that the misshapen ZP could deform the embryo. This is consistent with previous studies reporting on Myh9 mutant embryos being more deformable than WT (Maître et al., 2016) and on the influence of the ZP on the shape of the blastocyst (Kurotaki et al., 2007; Motosugi et al., 2005). Experimental deformation of the embryo was reported to affect cell fate (Niwayama et al., 2019; Royer et al., 2020). In the range of deformation of the ZP observed in mutant embryos, we found weak correlations between the shape of the ZP and CDX2 or SOX2 levels (Figure 2—figure supplement 1H–I, CDX2 in outer cells of 77 embryos from all genotypes combined but WT, Pearson’s R = 0.315, p<10−2, SOX2 in the inner cells of 58 embryos, Pearson’s R = 0.223, p > 10−1). This suggests that defects in lineage specification of maternal Myh9 mutant embryos do not simply result from the deformation of these blastocysts by their ZP. From this multiscale analysis, we conclude that maternal-zygotic loss of Myh9 or Myh10 has little impact on lumen formation and that maternal loss of Myh9 impacts the shape of the blastocyst indirectly by its initial effect on the structure of the ZP.
Maternal Myh9 mutants show defective cytokinesis and reduced cell number, which could constitute the cause for the defects in morphogenesis and lineage specification. To separate the effects of impaired contractility and defective cell divisions, we decided to reduce cell number by fusing blastomeres of WT embryos together. Reducing cell number by ¼ or ½ at the 4-cell stage results in embryos compacting with the same magnitude and forming a lumen concomitantly to control embryos (Figure 2—figure supplement 2A–C, Figure 2—video 4, Figure 3—figure supplement 2B). Also, embryos with reduced cell numbers differentiate into TE and ICM identically to control embryos as far as lineage proportions and fate marker levels are concerned (Figure 3—figure supplement 2A,C–E). Therefore, the morphogenesis and lineage specification defects observed in maternal Myh9 mutants are not likely to result simply from cytokinesis defects and their impact on cell number.
Together, these analyses reveal the critical role of MYH9 in setting global cell contractility on short and long timescales in order to effectively drive compaction, cytokinesis, and lineage specification. Comparably, the function of MYH10 during early blastocyst morphogenesis is less prominent. Importantly, the similarity of maternal homozygous and maternal heterozygous mutants indicates that the preimplantation embryo primarily relies on the maternal pools of MYH9. We conclude that maternally provided MYH9 is the main NMHC powering actomyosin contractility during early preimplantation development.
Despite MYH9 being the main NMHC provided maternally, the successful cleavages, shape changes, and differentiation observed in mMyh9 and mzMyh9 embryos suggest that some compensation by MYH10 could occur in these embryos. To test for compensations between the two NMHC paralogs expressed during preimplantation development, we generated double maternal-zygotic Myh9 and Myh10 knockout (mzMyh9;mzMyh10) embryos.
Nested time-lapse revealed that mzMyh9;mzMyh10 embryos fail most attempts of cytokinesis (Figure 5A, Figure 5—video 1). In addition to failed cytokinesis, mzMyh9;mzMyh10 embryos show increased cell cycle durations, which are more severe than those for mzMyh9 embryos (Figure 5A–B, Appendix 1—table 1–2). This results in mzMyh9;mzMyh10 embryos with only 2.9 ± 0.5 cells when reaching the blastocyst stage (Figure 6B). In fact, they occasionally develop into blastocyst-stage embryos consisting of only one single cell (1/8 embryos). Of those which succeed in dividing at least once, compaction after the third cleavage is weak with contact angles for mzMyh9;mzMyh10 embryos capping at 117 ± 4° compared to 147 ± 2° for WT (mean ± SEM, 3 and 23 embryos; Figure 5B, Appendix 1—table 1, Figure 5—video 1). Consistent with previous observations, periodic contractions are undetectable in any of the double mutants that we analyzed (Figure 5D–E, Figure 2—video 2). Together, this indicates that double maternal-zygotic Myh9 and Myh10 mutants generate extremely weak contractile forces compared to WT and single maternal-zygotic Myh9 or Myh10 mutants.
When investigating fate specification (Figure 6), CDX2 is present in 5/7 embryos as compared to all the 23 WT embryos we analyzed (Figure 6F). SOX2 is only detected when embryos succeed in internalizing at least one cell (Figure 6A,C–E and G). No maternal Myh9;Myh10 mutant embryo consisting of only two cells contained an inner cell, half of embryos with 3–5 cells contained a single inner cell, and all embryos with six cells or more contained inner cells (Figure 6D). Moreover, the levels of CDX2 in outer cells are reduced compared to WT embryos, as observed previously for single maternal-zygotic Myh9 mutants. Consistently, YAP is enriched in the nucleus of outer cells, albeit at lower levels than in WT (Figure 3—figure supplement 1). As for single mutants, the apical marker PRKCz, F-actin, the cell-cell adhesion molecule CDH1, and members of the fluid-pumping machinery ATP1A1 and AQP3 are correctly apico-basally polarized in double mutants (Figure 7). The presence of CDX2, nuclear YAP, and the correct organization of apico-basal polarity suggest that mzMyh9;mzMyh10 embryos can initiate differentiation into TE, the epithelium responsible for making the blastocoel. The ability of mzMyh9;mzMyh10 embryos to create de novo a functional polarized epithelium is further supported by the fact that they can eventually proceed with polarized fluid accumulation and create a blastocoel (Figure 5A, Figure 5—video 1). As observed in single maternal Myh9 mutants, mzMyh9;mzMyh10 embryos are not delayed to initiate lumen formation despite their extended cell cycles (Figure 5C, Figure 5—video 1). Also, we measure that mutant embryos grow at rates that are similar to WT ones (5.8 ± 1.5 and 3.9 ± 0.5 µm2/min, mean ± SEM, 5 and 20 embryos, Student’s t test p>10−2; Figure 5C). This indicates that contractility does not influence the initial growth rate of the blastocoel and that blastocoel formation does not require powerful actomyosin contractility.
Finally, we measure similar metrics for all single and double heterozygous Myh9 and Myh10 mutant embryos (Figure 5, Figure 6, Appendix 1—table 1), indicating once again that maternal contributions predominantly set the contractility for preimplantation development. We conclude that after the maternal loss of both Myh9 and Myh10, contractility is almost entirely abolished. This effect is much stronger than that after the loss of maternal MYH9 only and suggests that, in single maternal Myh9 mutants, MYH10 can compensate significantly, which we would not anticipate from our previous single mzMyh10 knockout analysis. Therefore, despite MYH9 being the main engine of preimplantation actomyosin contractility, MYH10 ensures a substantial part of blastocyst morphogenesis in the absence of MYH9. The nature and extent of this compensation will need further characterization.
Embryos without maternal MYH9 and MYH10 can fail all successive cleavages when reaching the time of the blastocyst stage (18/53 embryos, all Myh9 and Myh10 mutant genotypes combined across seven experiments; Figure 8A, Figure 8—video 1). In single-celled embryos, multiple cleavage attempts at intervals of 10–20 hr can be observed, suggesting that the cell cycle is still operational in those embryos (Figure 5—video 1). This is further supported by the presence of multiple large nuclei in single-celled embryos, indicative of preserved genome replication (Figure 8C). Interestingly, these giant nuclei contain CDX2 and YAP, but no SOX2, suggesting that, in addition to the cell cycle, the lineage specification program is still partially operational (Figure 8C–E, Figure 3—figure supplement 1). Strikingly, we also observed that at the time of blastocoel formation, single-celled maternal Myh9 and Myh10 mutant embryos begin to swell to sizes comparable to normal blastocysts (Figure 8A–B, Figure 8—video 1). Single-celled embryos then form, within their cytoplasm, tens of fluid-filled vacuolar compartments, which can inflate into structures comparable in size to the blastocoel (Figure 8A and C, Figure 8—video 1). The membrane of these cytoplasmic vacuoles contains the fluid pumping machinery ATP1A1 and AQP3, which is specific of basolateral membranes in multicellular embryos of all considered genotypes (Figure 7; Barcroft et al., 2003; Barcroft et al., 2004). This indicates that single-celled embryos are able to establish apico-basal polarity and to direct fluid pumping into a basolateral compartment despite the absence of neighbouring cells. When measuring the growth rates of single-celled embryos, we found that they are comparable to the ones of multiple-celled mutant embryos or WT (4.1 ± 0.8, 5.8 ± 1.5, and 3.9 ± 0.5 µm2/min, mean ± SEM, 4, 5, and 20 embryos, Student’s t test p > 10−2 ; Figure 8B), indicating that they are able to accumulate fluid as fast as embryos composed of multiple cells. Therefore, single-celled embryos are able to initiate TE differentiation and display some attributes of epithelial function. Unexpectedly, this also indicates that fluid accumulation during blastocoel formation is cell-autonomous. Together, this further indicates that the developmental program entailing morphogenesis and lineage specification carries on independently of successful cleavages.
To further test whether fluid accumulation is cell-autonomous without disrupting actomyosin contractility, we fused all blastomeres at the late morula stage before lumen formation (Figure 8—figure supplement 1A, Figure 8—video 2). The nuclei from the fused cells displayed high CDX2 and low SOX2 levels, which indicates that fused embryos retain a TE phenotype (Figure 8—figure supplement 1C–E). Moreover, similarly to single-celled embryos resulting from the loss of contractility, single-celled embryos resulting from cell fusion grew in size at rates similar to those of control embryos while forming large fluid-filled vacuoles (3.3 ± 0.4 and 3.7 ± 0.4 µm2/min, 7 and 8 embryos, Student’s t test p > 10−2; Figure 8—figure supplement 1A–B, Figure 8—video 2). This further confirms that the initiation of fluid accumulation and its rate during blastocoel morphogenesis can rely entirely on transcellular transport and are independent from cell-cell contacts and its associated paracellular transport.
Together, our experiments with single and double maternal-zygotic NMHC knockout embryos reveal that, while MYH9 is the major NMHC powering sufficient actomyosin contractility for blastocyst morphogenesis, MYH10 can significantly compensate the effect of MYH9 loss onto cytokinesis and compaction. Mutant and fused embryos also reveal that even blastocyst-stage embryos made out of a single cell can proceed with the preimplantation program in a timely fashion, as they differentiate into TE and build features of the blastocyst, such as the inflation of fluid-containing compartments. Finally, myosin mutants and fused embryos reveal that the developmental program entailing morphogenesis and lineage specification carries on independently of successful cleavages. This further demonstrates the remarkable regulative capacities of the early mammalian embryo.
Recent studies have described the critical role of actomyosin contractility in establishing the blastocyst (Anani et al., 2014; Chan et al., 2019; Dumortier et al., 2019; Maître et al., 2015; Maître et al., 2016; Samarage et al., 2015; Zenker et al., 2018; Zhu et al., 2017). To understand the molecular regulation of this crucial engine of preimplantation development, we have eliminated the maternal and zygotic sources of the NMHCs MYH9 and MYH10 individually and jointly. Maternal-zygotic mutants reveal that actomyosin contractility is primarily mediated by maternal MYH9, which is found most abundantly. Comparatively, loss of Myh10 has a mild impact on preimplantation development. Nevertheless, double maternal-zygotic mutants reveal that in the absence of MYH9, MYH10 plays a critical role in ensuring sufficient contractility to power cleavage divisions. Furthermore, double maternal-zygotic mutants bring to light the remarkable ability of the preimplantation embryo to carry on with its developmental program even when reduced to a single-celled embryo. Indeed, single-celled embryos, obtained from NMHC mutants or from the fusion of all cells of WT embryos, display evident signs of differentiation and initiate lumen formation by accumulating fluid in a timely fashion. Therefore, NMHC mutants and fused embryos reveal that the developmental program entailing morphogenesis and lineage specification carries on independently of successful cleavages.
Despite the importance of contractility during the formation of the blastocyst, maternal-zygotic mutants of NMHCs are yet to be characterized. The phenotypes we report here further confirm some of the previously proposed roles of contractility during preimplantation development and provide molecular insights on which NMHC paralog powers contractility. We observed reduced compaction when Myh9 is maternally deleted and slower compaction when Myh10 is deleted (Figure 2A–B). This is in agreement with cell culture studies, in which Myh9 knockdown reduces contact size whereas Myh10 knockdown does not (Heuzé et al., 2019; Smutny et al., 2010). This is also in agreement with previous studies using inhibitory drugs on the preimplantation embryo. Compaction is prevented, and even reverted, when embryos are treated with blebbistatin, a drug directly inhibiting NMHC function (Maître et al., 2015), or ML7, an inhibitor of the myosin light chain kinase (Zhu et al., 2017). However, zygotic injection of siRNA targeting Myh9 did not affect compaction (Samarage et al., 2015; Zenker et al., 2018), further indicating that MYH9 acts primarily via its maternal pool. Similarly, siRNA-mediated knockdown of a myosin regulatory light chain Myl12b did not affect compaction (Zhu et al., 2017). Therefore, for efficient reduction of contractility with molecular specificity, maternal depletion is required.
The phenotypes of the maternal-zygotic NMHC mutants can also appear in contradiction with other conclusions from previous studies. Drugs were used to test the role of contractility in apico-basal polarity establishment with contradictory results. ML7, but not blebbistatin, was reported to block de novo cell polarization (Zhu et al., 2017). This discrepancy might be due to ML7 inhibiting other kinases than MLCK such as PKC (Bain et al., 2003), which is required for apical domain formation (Zhu et al., 2017). Also, blebbistatin was reported to block the maturation of the apical domain (Zenker et al., 2018). The apical domain is essential for TE differentiation and for polarized fluid transport (Laeno et al., 2013; Hirate et al., 2013). We observed that even the most severely affected NMHC mutant embryos are able to establish and maintain apico-basal polarity, specific expression of TE markers and, most importantly, a functional polarized fluid transport (Figure 8). This argues against the requirement of contractility for de novo polarization and apical domain maturation.
Besides compaction defects, reduced cell number is one of the major effects caused by reduced contractility in the maternal-zygotic knockout of NMHCs. Loss of MYH9 alone, but not of MYH10 alone, causes cytokinesis defects (Figures 2–3, Figure 2—videos 1 and 3). This could simply be explained by the higher levels of maternal MYH9 (Figure 1). In vitro studies also noted that MYH9, but not MYH10, is key to power the ingression of the cleavage furrow (Taneja et al., 2020). This recent study also noted that MYH10 can compensate the absence of MYH9 with increased cortical recruitment (Taneja et al., 2020). Consistently, we observed much more severe division failures when both Myh9 and Myh10 are maternally removed (Figures 5, 6 and 8). This reveals significant compensation between NMHCs during preimplantation development. Whether this compensation takes place by a change in subcellular localization or by changes in expression level will require further studies.
Reduced cell number could have a major impact during very early development, when the zygote needs to produce enough cells for developmental patterning and morphogenesis. During normal development, the mouse embryo paces through the successive morphogenetic steps of compaction, internalization, and lumen formation at the rhythm of the third, fourth, and fifth waves of cleavage (Maître, 2017; Płusa and Piliszek, 2020; Rossant, 2016; White et al., 2018). Such concomitance may initially suggest that the preimplantation program is tightly linked to cleavages and cell number. However, seminal studies have established that the mammalian embryo is regulative and can build the blastocyst correctly with either supernumerary or fewer cells (Smith and McLaren, 1977; Snow, 1973; Tarkowski, 1959; Tarkowski, 1961; Tarkowski and Wróblewska, 1967). For example, aggregating multiple embryos results in compaction and lumen formation after the third and fifth cleavage, respectively, rather than when the chimeric embryos are composed of 8 and 32 cells (Tarkowski, 1961). Disaggregation leads to the same result with halved or quartered embryos compacting and forming a lumen at the correct embryonic stages rather than when reaching a defined cell number (Tarkowski, 1959; Tarkowski and Wróblewska, 1967). Contrary to disaggregated embryos, NMHC mutant embryos show reduced cell numbers without affecting the amount of cellular material (Figure 2—figure supplement 1). As observed in other species, the pace of development during mouse cleavage stages is thought to depend on the size ratio between the nucleus and the cytoplasm (Tsichlaki and FitzHarris, 2016). Evidences of nuclear divisions are visible even in the case of single-celled embryos (Figure 8—video 1), which suggests that the nuclear to cytoplasmic ratio may increase during the development of single-celled embryos. In line with these previous studies, the present experiments further confirm that compaction, internalization, and lumen formation take place without the expected cell number. Therefore, although cleavages and morphogenetic events are concomitant, they are not linked. Importantly, affecting blastocyst cell number through maternal Myh9 loss or fusion of blastomeres at the 4-cell stage preserves the proportion of cells allocated to TE and ICM lineages (Figure 3C and Figure 3—figure supplement 2D). A recent study proposed that this proportion is controlled by the growth of the lumen (Chan et al., 2019). This is compatible with our observation that lumen growth is not affected by the loss of Myh9 or cell fusion (Figure 2C and Figure 2—figure supplement 2C). However, lineage proportions break down when both Myh9 and Myh10 are maternally lost (Figure 6C). With about three cells on an average (Figure 6C–D), a majority of double mutants fail to internalize cells. As observed for doublets of 16-cell stage blastomeres, in principle, two cells should be enough to internalize one cell by an entosis-like process (Maître et al., 2016; Overholtzer et al., 2007). With extremely low contractility, double mutants may fail to raise contractility above the tension asymmetry threshold, enabling internalisation (Maître et al., 2016). As for oriented cell division (Korotkevich et al., 2017), this mechanism needs at least two cells to push one dividing cell within the cell-cell contact area. Together, this explains the absence of inner cells in mutant embryos with fewer than three cells.
Disaggregation experiments were key to reveal some of the cell-autonomous aspects of blastocyst formation: a single 8-cell stage blastomere can polarize (Ziomek and Johnson, 1980) and increase its contractility (Maître et al., 2015). Our observations on single-celled embryos reveal that fluid accumulation is also a cell-autonomous process (Figure 8). In fact, single-celled embryos inflate at rates similar to control embryos, implying that cell-cell contacts, closed by tight junctions at the embryo surface, are not required for accumulating fluid within blastomeres. Therefore, blastocoel components may be transported exclusively transcellularly, whereas paracellular transport through tight junctions may be negligible.
Whether single-celled embryos resulted from systematically failed cytokinesis or from cell fusion, these embryos grow at a similar rate, which is also the same as control embryos and other embryos composed of a reduced cell number (Figure 2C, Figure 5C, Figure 8B, Figure 8—figure supplement 1B, and Figure 2—figure supplement 2C). This suggests that fluid accumulation is a robust machinery during preimplantation development. Interfering with aquaporins, ion channels and transporters affect fluid accumulation, but the transcellular and paracellular contributions remain unclear (Barcroft et al., 2003; Kawagishi et al., 2004; Schliffka and Maître, 2019). Future studies will be needed to understand what sets robust transcellular fluid accumulation during preimplantation development. The ability of single cells to polarize and inflate a lumen was recently demonstrated in vitro by plating hepatocytes onto CDH1-coated substrates (Zhang et al., 2020). In this study, fluid accumulation in single-celled embryos does not result in the formation of a lumen but in the formation of inflating vacuoles. Vacuoles were also reported to appear occasionally in mutant mouse embryos with defective cell-cell adhesion (Bedzhov et al., 2012; Stephenson et al., 2010). Similarly, vacuole formation in case of acute loss of cell-cell adhesion has been studied in vitro (Vega-Salas et al., 1988). When apical lumens are disrupted, the apical compartment is internalized, and this can result in fluid accumulation within the vacuolar apical compartment (VAC) (Vega-Salas et al., 1988). Analogous VACs were proposed to coalesce into the lumen of endothelial tubes upon cell-cell contact in vivo (Kamei et al., 2006). The molecular characteristics and dynamics of these structures and their empty counterparts, the so-called apical membrane initiation sites, have been extensively studied in vitro and proven helpful to better understand apical lumen formation (Bryant et al., 2010; Overeem et al., 2015). In the case of the blastocyst, which forms a lumen on its basolateral side (Dumortier et al., 2019; Schliffka and Maître, 2019), such vacuoles may constitute an equivalent vacuolar basolateral compartment. Similar to apical lumen, further characterization of the molecular identity and dynamic behaviors of these vacuoles may prove useful to better understand fluid accumulation during basolateral lumen formation. Studying transcellular fluid transport and the molecular machinery of basolateral lumen formation will be greatly facilitated by the fusion approach reported in the present study (Figure 8—figure supplement 1).
All the animal works were performed in the animal facility at the Institut Curie, with permission from the institutional veterinarian overseeing the operation (APAFIS #11054–2017082914226001). The animal facilities are operated according to international animal welfare rules.
Embryos were isolated from superovulated female mice mated with male mice. Superovulation of female mice was induced by intraperitoneal injection of 5 international units (IU) pregnant mare’s serum gonadotropin (Ceva, Syncro-part), followed by intraperitoneal injection of 5 IU human chorionic gonadotropin (MSD Animal Health, Chorulon) 44–48 hr later. Embryos at E0.5 were recovered from plugged females by opening the ampulla followed by a brief treatment with 37°C 0.3 mg/mL hyaluronidase (Sigma, H4272-30MG) and washing in 37°C FHM. Embryos were recovered at E1.5 by flushing oviducts and at E2.5 and E3.5 by flushing oviducts and uteri from plugged females with 37°C FHM (Millipore, MR-122-D) using a modified syringe (Acufirm, 1400 LL 23).
Embryos were handled using an aspirator tube (Sigma, A5177-5EA) equipped with a glass pipette pulled from glass micropipettes (Blaubrand intraMark or Warner Instruments).
Embryos were placed in KSOM (Millipore, MR-107-D) supplemented with 0.1% BSA (Sigma, A3311) in 10 μL droplets covered in mineral oil (Acros Organics). Embryos are cultured in an incubator under a humidified atmosphere supplemented with 5% CO2 at 37°C.
To remove the ZP, embryos were incubated for 45–60 s in pronase (Sigma, P8811).
Blastomeres were fused using the GenomONE-CF FZ SeV-E cell fusion kit (CosmoBio, ISK-CF-001-EX). HVJ envelope was resuspended following manufacturer’s instructions and diluted in FHM for use. To fuse the blastomeres of embryos at the 4-cell stage, embryos were incubated in 1:60 HVJ envelope/FHM for 15 min at 37°C followed by washes in KSOM. To fuse blastomeres at the morula stage, embryos were treated in the same manner in 1:50 HVJ envelope/FHM. Fusion typically completes ~30 min after the treatment.
For imaging, embryos were placed in 3.5 or 5 cm glass-bottom dishes (MatTek).
Mice used were of 5 weeks old and above.
(C57BL/6xC3H) F1 hybrid strain was used for WT.
To remove LoxP sites specifically in oocytes, Zp3Cre/+ (Tg(Zp3-cre)93Knw) mice were used (de Vries et al., 2000).
To generate mzMyh9 embryos, Myh9tm5RSad mice were used (Jacobelli et al., 2010) to breed Myh9tm5RSad/tm5RSad; Zp3Cre/+ females with Myh9+/− ±. To generate mzMyh10 embryos, Myh10tm7Rsad mice were used (Ma et al., 2009) to breed Myh10tm7Rsad/tm7Rsad; Zp3Cre/+ females with Myh10+/− ±. To generate mzMyh9;mzMyh10 embryos, Myh9tm5RSad/tm5RSad; Myh10tm7Rsad/tm7Rsad; Zp3Cre/+ females were mated with Myh9+/−; Myh10+/− males. To generate embryos with a maternal Myh9-GFP allele, Myh9tm8.1RSad (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo) females were mated with WT males; to generate embryos with a paternal Myh9-GFP allele, WT females were mated with Myh9tm8.1RSad (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo) males (Muzumdar et al., 2007; Zhang et al., 2012). For fusion at the morula stage, (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo) mice were used (Muzumdar et al., 2007).
Embryos were fixed in 2% PFA (Euromedex, 2000-C) for 10 min at 37°C, washed in PBS, and permeabilized in 0.1% (SOX2, CDX2, and YAP primary antibodies) or 0.01% (all other primary antibodies) Triton X-100 (Euromedex, T8787) in PBS (PBT) at room temperature before being placed in blocking solution (PBT with 3% BSA) at 4°C for 2–4 hr. Primary antibodies were applied in blocking solution at 4°C overnight. After washes in PBT at room temperature, embryos were incubated with secondary antibodies, DAPI, and/or phalloidin in blocking solution at room temperature for 1 hr. Embryos were washed in PBT and imaged immediately after.
|Phospho-MYH9 (Ser1943)||1:200||Cell Signaling, 5026||AB_10576567|
|MYH10||1:200||Santa Cruz, sc-376942|
|PRKCz (H-1)||1:50||Santa Cruz, sc-17781||AB_628148|
|Secondary antibodies and dyes||Dilution||Provider||RRID|
|Alexa Fluor Plus 488 anti-mouse||1:200||Invitrogen, A32723||AB_2633275|
|Alexa Fluor 546 anti-mouse||1:200||Invitrogen, A11003||AB_2534071|
|Alexa Fluor Plus 488 anti-rabbit||1:200||Invitrogen, A32731||AB_2633280|
|Alexa Fluor Plus 546 anti-rabbit||1:200||Invitrogen, A11010||AB_2534077|
|Alexa Fluor 633 anti-rat||1:200||Invitrogen, A21094||AB_141553|
|Alexa Fluor 488 anti-rat||1:200||Invitrogen, A11006||AB_2534074|
|Alexa Fluor 633 phalloidin||1:200||Invitrogen, A22284|
|4′,6-diamidino-2-phenylindole (DAPI)||1:1000||Invitrogen, D1306||AB_2629482|
DNA extraction was performed on single fixed embryos, in 10 µL of DNA extraction buffer containing 10 mM Tris-HCl (pH 8, Sigma, T2694), 50 mM KCl (Sigma, 60142), 0.01% gelatine (Sigma, G1393), 0.1 mg/mL proteinase K (Sigma, P2308) at 55°C for 90 min, followed by deactivation of the proteinase K at 90°C for 10 min. 2 µL of this DNA extract was used in PCR reactions.
To assess the Myh9 genotype, a preamplification PCR was performed using forward (fw) primer GGGACCCACTTTCCCCATAA/reverse (rev) primer GTTCAACAGCCTAGGATGCG at a final concentration of 0.4 µM. The PCR program is as follows: denaturation at 94°C 4 min; 35 cycles of 94°C 1 min, 58°C 1 min, 72°C 3:30 min, 72°C 1 min; final elongation step at 72°C 7 min. Subsequently, 2 µL of the PCR product was directly used as a template for two independent PCR amplifications to detect either a 592 bp amplicon for the WT allele, with fw primer GGGACACAGTTGAATCCCTT/rev primer ATGGGCAGGTTCTTATAAGG or a 534 bp amplicon for a mutant allele, with fw primer GGGACACAGTTGAATCCCTT/rev primer CATCCTGTGGAGAGTGAGAGCAC at a final concentration of 0.4 µM. PCR program is as follows: denaturation at 94°C for 4 min; 35 cycles of 94°C 1 min, 58°C 2 min, 72°C 1 min; final elongation step at 72°C 7 min.
To assess the Myh10 genotype, a preamplification PCR was performed using fw primer GGCCCCCATGTTACAGATTA/rev primer TTTCCTCAACATCCACCCTCTG at a final concentration of 0.4 µM. The PCR program is as follows: denaturation at 94°C for 4 min; 35 cycles of 94°C 1 min, 58°C 1 min, 72°C 2 min, 72°C 1 min; final elongation step at 72°C 7 min. Subsequently, 2 µL of the PCR product was directly used as a template for a PCR amplification using fw primer 1 TAGCGAAGGTCTAGGGGAATTG/fw primer 2 GACCGCTACTATTCAGGACTTATC/rev primer CAGAGAAACGATGGGAAAGAAAGC at a final concentration of 0.4 µM. PCR program is as follows: denaturation at 94°C for 4 min; 35 cycles of 94°C 1 min, 58°C 1:30 min, 72°C 1 min; final elongation step at 72°C 7 min, resulting in a 230 bp amplicon for a WT allele and a 630 bp amplicon for a mutant allele.
To extract total RNA, embryos were collected in 3 µL of PBS, frozen on ice or snap-frozen on dry ice and stored at −80°C until further use. Total RNA extraction was performed using the PicoPure RNA Isolation Kit (ThermoFisher Scientific, KIT0204) according to manufacturer’s instructions. DNase treatment was performed during the extraction, using RNase-Free DNase Set (QIAGEN, 79254). cDNA was synthesized with random primers (ThermoFisher Scientific, 48190011), using the SuperScript III Reverse Transcriptase kit (ThermoFisher Scientific, 18080044) on all the extracted RNA, according to manufacturer’s instructions. The final product could be used immediately or stored at −20°C until further use.
All the RT-qPCR reactions were performed using the ViiA 7 Real-Time PCR machine (Applied BioSystems) according to the instruction of the manufacturer. For each target sample, amplifications were run in triplicate in 10 µL reaction volume containing 5 µL of 2x Power SYBR Green PCR Master Mix (Applied Biosystems, 4367659), 1.4 µL of cDNA, 0.5 µL of each primer at 2 μM, and 2.6 µL of nuclease-free water. The PCR program is as follows: denaturation at 95°C 10 min; 40 cycles of 95°C 15 s, 60°C 1 min; 1 cycle of 95°C 15 s, 60°C 1 min, 95°C 15 s. The last cycle provides the post PCR run melt curve, for assessment of the specifics of the amplification. Each couple of primers was designed in order to anneal on consecutive exons of the cDNA sequence, far from the exon-exon junction regions, except for the Gapdh gene. The size of amplicons varied between 84 bp and 177 bp. Gapdh housekeeping gene was used as internal control to normalize the variability in expression levels of each target gene, according to the 2-ΔCT method. For every experiment, data were further normalized to Myh9 levels at the zygote stage.
Total RNA was extracted from 234, 159, 189, 152 embryos at zygote, four-cell, morula, and blastocyst stages, respectively, from six independent experiments.
|Gene name||Primer sequence forward||Primer sequence reverse|
Mouse and human single cell RNA sequencing data were extracted from Deng et al., 2014 and Yan et al., 2013, analyzed as in De Iaco et al., 2017. In brief, single cell RNAseq datasets of human and mouse embryos (GSE36552, GSE45719) were downloaded and analyzed using the online platform Galaxy (usegalaxy.org). The reads were aligned to the reference genome using TopHat (Galaxy Version 2.1.1; Kim et al., 2013) and read counts generated with htseq-count (Galaxy Version 0.9.1; Anders et al., 2015). Normalized counts were determined with limma-voom (Galaxy Version 3.38.3 + galaxy3; Law et al., 2014).
For live imaging, embryos were placed in 5 cm glass-bottom dishes (MatTek) under a Celldiscoverer 7 (Zeiss) equipped with a 20x/0.95 objective and an ORCA-Flash 4.0 camera (C11440, Hamamatsu) or a 506 axiovert (Zeiss) camera.
Embryos were imaged from E1.5 to E3.5 until the establishment of a stable blastocoel in WT control embryos. Using the experiment designer tool of ZEN (Zeiss), we set up a nested time-lapse in which all embryos were imaged every 30 min at three focal planes positioned 10 µm apart for 40–54 hr and each embryo was subjected to two 10 min-long acquisitions with an image taken every 5 s at two focal planes positioned 10 µm apart that were set 12 and 19 hr after the second cleavage division of a reference WT embryo. Embryos were kept in a humified atmosphere supplied with 5% CO2 at 37°C. After imaging, mutant embryos were tracked individually for immunostaining and genotyping.
Live MYH9-GFP embryos were imaged at the zygote, four-cell, morula, and blastocyst stages. Live imaging was performed using an inverted Zeiss Observer Z1 microscope with a CSU-X1 spinning disc unit (Yokogawa). Excitation was achieved using 488 and 561 nm laser lines through a 63x/1.2 C Apo Korr water immersion objective. Emission was collected through 525/50 and 595/50 band pass filters onto an ORCA-Flash 4.0 camera (C11440, Hamamatsu). The microscope was equipped with an incubation chamber to keep the sample at 37°C and supply the atmosphere with 5% CO2.
Immunostainings were imaged on the same microscope using 405, 488, 561, and 642 nm laser lines through a 63x/1.2 C Apo Korr water immersion objective; emission was collected through 450/50 nm, 525/50 nm, 595/50 band pass or 610 nm low pass filters.
Based on the time-lapses of preimplantation development from E1.5 to E3.5, we assessed the timing of the third, fourth, and fifth cleavage divisions as well as the dynamics of compaction and lumen growth following these definitions:
(1)Cleavages are defined as part of the same wave when they occur within 30 min of the cleavage of another cell within the same embryo. As embryos are recovered at E1.5, time-lapse imaging starts around the time of the second cleavage. As cell divisions are affected by the mutations of Myh9 and/or Myh10, the cell number of recovered embryos is not necessarily equal to WT cell number. Therefore, we used the entire time-lapse to determine whether the first observed division corresponds to thesecond, third, fourth, or fifth wave. Failed cytokinesis is counted as part of cleavage waves. (2) Timing of maximal compaction is defined as the time when embryos stop increasing their contact angles. (3) Timing of blastocoel formation is taken as the time when a fluid compartment with a diameter of at least 20 µm is visible.
The timings of all cleavage divisions and morphogenetic events were normalized to the end of the third cleavage division (beginning of the 8-cell stage in WT embryos).
Surface contact angles were measured using the angle tool in Fiji. Only the contact angles formed by two adjacent blastomeres with their equatorial planes in focus were considered. For each embryo, between one and six contact angles were measured after completion of the third cleavage, just before the onset of the fourth cleavage, after completion of the fourth cleavage, and just before the onset of the fourth cleavage.
Lumen growth was assessed by an increase in the area of the embryo. Using FIJI, an ellipse was manually fitted around the embryo every hour starting from the time of blastocoel formation (defined here as when a lumen of at least 20 µm becomes visible) until the end of the time-lapse. Growth rates of individual embryos were calculated over a 7 hr time window following the time of blastocoel formation. Measured projected areas from different embryos were synchronized to the time of blastocoel formation and averaged. For a fused single-celled embryo, the mean blastocoel formation time of the control embryos from each experiment was calculated to synchronize the fused embryos (1 hr of deviation from the mean blastocoel formation time can be allowed to accommodate cell divisions and sampling time). For control embryos, only blastocyst growing by at least 35% of their projected area were considered.
The shape of the zona pellucida was measured by fitting an ellipse on the outer edge of the zona pellucida and measuring the long and short axes.
Particle image velocimetry (PIV) analysis was performed using PIVlab 2.02 running on Matlab (Thielicke and Stamhuis, 2020; Thielicke and Stamhuis, 2014). Similar to Maître et al., 2015, time-lapse movies acquired every 5 s were processed using two successive passes through interrogation windows of 20/10 µm resulting in ∼180 vectors per embryo. Vector velocities were then exported to Matlab for Fast Fourier Transform (FFT) analysis. The power spectrum of each embryo was then analyzed to assess the presence of a clear oscillation peak. The peak value between 50 and 120 s was taken as the amplitude, as this oscillation period range corresponds to the one where WT show oscillations (Maître et al., 2015; Maître et al., 2016). An embryo is considered as oscillating when the amplitude peaks 1.7 above background (taken as the mean value of the power spectrum signal of a given embryo) to determine whether it has a detectable oscillation. Power spectra of embryos from the same genotype were averaged.
Myh9-GFP intensity was measured in FIJI by fitting a circle with a radius of 50 µm over the sum projection of each embryo and measuring the mean gray value. Background intensity was measured in a circular area with radius 5 µm and subtracted to the embryonic value. The corrected intensities were normalized to the zygote stage of maternal Myh9-GFP embryos.
We used FIJI to measure the levels of SOX2, CDX2, and YAP expression and localization by measuring the signal intensity of immunostainings. For each embryo, 15 cells (five ICM, five polar TE, five mural TE) were measured. In case an embryo had fewer than five ICM cells, a corresponding number of TE cells were added. If the embryo had fewer than 15 cells, all cells were measured. For each cell, the signal intensity was measured in a representative 3.7 µm2 circular area of the equatorial nuclear plane and in a directly adjacent cytoplasmic area. Mitotic and apoptotic cells were excluded from analysis. We then calculated the nuclear to cytoplasmic ratio.
To obtain apico-basal intensity profiles of polarity markers, we selected confocal slices cutting through the equatorial plane of a surface cell lining the blastocoel. We drew a 15-µm-long and 0.4-µm-thick line from the cell-medium interface through the cell into the cell-lumen or cell-vacuole interface. Lowest/highest intensity values were normalized to 0 and 1, respectively.
To count cell number, we used DAPI to detect nuclei and phalloidin staining to detect cells. Cells were considered outer cells if they were in contact with the outside medium.
To measure the 3D properties of blastocysts, we manually segmented the surface of the embryo and of the blastocoel using Bitplane Imaris. Volumes and ellipticity were obtained from Imaris. The cellular volume was obtained by subtracting the blastocoel volume from the total volume of the embryo.
Mean, standard deviation, SEM, lower and upper quartiles, median, Pearson’s correlation coefficients, unpaired two-tailed Welch’s t test, Mann-Whitney U test, and Pearson’s Chi2 test with Yates’s correction for continuity p values were calculated using Excel (Microsoft) and R (http://www.r-project.org). Pearson’s correlation statistical significance was determined on the corresponding table. Statistical significance was considered when p<10−2. Boxplots show the median (line), interquartile range (box), 1.5 x interquartile range (whiskers), and remaining outliers (dots).
The sample size was not predetermined and simply results from the repetition of experiments. No sample was excluded. No randomization method was used. The investigators were not blinded during experiments.
The microscopy data, ROI and analyses are available on the following repository under a CC BY- NC-SA license: https://ressources.curie.fr/mzmyh/.
Multipotent cell lineages in early mouse development depend on SOX2 functionGenes & development 17:126–140.https://doi.org/10.1101/gad.224503
The specificities of protein kinase inhibitors: an updateThe Biochemical journal 371:199–204.https://doi.org/10.1042/BJ20021535
Nonmuscle myosin II isoforms coassemble in living cellsCurrent biology : CB 24:1160–1166.https://doi.org/10.1016/j.cub.2014.03.071
A molecular network for de novo generation of the apical surface and lumenNature cell biology 12:1035–1045.https://doi.org/10.1038/ncb2106
Defects in cell adhesion and the visceral endoderm following ablation of nonmuscle myosin heavy chain II-A in miceThe Journal of biological chemistry 279:41263–41266.https://doi.org/10.1074/jbc.C400352200
Na+/H+ Exchanger-3 is involved in mouse blastocyst formationJournal of Experimental Zoology 301A:767–775.https://doi.org/10.1002/jez.a.90
E-cadherin junctions as active mechanical integrators in tissue dynamicsNature cell biology 17:533–539.https://doi.org/10.1038/ncb3136
Conditional ablation of nonmuscle myosin II-B delineates heart defects in adult miceCirculation research 105:1102–1109.https://doi.org/10.1161/CIRCRESAHA.109.200303
Ablation of nonmuscle myosin II-B and II-C reveals a role for nonmuscle myosin II in cardiac myocyte karyokinesisMolecular biology of the cell 21:3952–3962.https://doi.org/10.1091/mbc.E10-04-0293
Pulsatile cell-autonomous contractility drives compaction in the mouse embryoNature cell biology 17:849–855.https://doi.org/10.1038/ncb3185
Polarity of the mouse embryo is established at blastocyst and is not prepatternedGenes & development 19:1081–1092.https://doi.org/10.1101/gad.1304805
Forcing cells into shape: the mechanics of actomyosin contractilityNature reviews. Molecular cell biology 16:486–498.https://doi.org/10.1038/nrm4012
Mechanisms of apical-basal axis orientation and epithelial lumen positioningTrends in cell biology 25:476–485.https://doi.org/10.1016/j.tcb.2015.04.002
Multiscale morphogenesis of the mouse blastocyst by actomyosin contractilityCurrent opinion in cell biology 66:123–129.https://doi.org/10.1016/j.ceb.2020.05.002
Common principles of early mammalian embryo self-organisationDevelopment 147:dev183079.https://doi.org/10.1242/dev.183079
Coupling changes in cell shape to chromosome segregationNature reviews. Molecular cell biology 17:511–521.https://doi.org/10.1038/nrm.2016.75
Making the Mouse Blastocyst: Past, Present, and FutureCurrent topics in developmental biology 117:275–288.https://doi.org/10.1016/bs.ctdb.2015.11.015
Cortical tension allocates the first inner cells of the mammalian embryoDevelopmental Cell 34:435–447.https://doi.org/10.1016/j.devcel.2015.07.004
Factors affecting the time of formation of the mouse blastocoeleJournal of Embryology and Experimental Morphology 41:79–92.
PIVlab – Towards User-friendly, Affordable and Accurate Digital Particle Image Velocimetry in MATLABJournal of Open Research Software 2:jors.bl.https://doi.org/10.5334/jors.bl
SoftwarePIVlab v2.36 - Time-Resolved Digital Particle Image Velocimetry Tool for MATLABPIVlab v2.36 - Time-Resolved Digital Particle Image Velocimetry Tool for MATLAB.
Non-muscle myosin II takes centre stage in cell adhesion and migrationNature reviews. Molecular cell biology 10:778–790.https://doi.org/10.1038/nrm2786
Instructions for Assembling the Early Mammalian EmbryoDevelopmental cell 45:667–679.https://doi.org/10.1016/j.devcel.2018.05.013
Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cellsNature structural & molecular biology 20:1131–1139.https://doi.org/10.1038/nsmb.2660
The contractome--a systems view of actomyosin contractility in non-muscle cellsJournal of cell science 128:2209–2217.https://doi.org/10.1242/jcs.170068
Symmetry Breaking in the Mammalian EmbryoAnnual review of cell and developmental biology 34:405–426.https://doi.org/10.1146/annurev-cellbio-100617-062616
Edward E MorriseySenior and Reviewing Editor; University of Pennsylvania, United States
In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.
[Editors' note: this paper was reviewed by Review Commons.]
Your study provides novel information regarding the role of Myh9 and Myh10 in preimplantation mammalian development. We feel that such information will lead to a better understanding to the initial steps in early embryo formation and cell fate specification.https://doi.org/10.7554/eLife.68536.sa1
Reviewer #1 (Evidence, reproducibility and clarity (Required)):
Previously, the authors showed the importance of contractile force in cell positioning and cell fate specification in preimplantation mouse development. In this study, the authors generated maternal-zygotic mutants of the nonmuscle myosin-II heavy chain (NMHC) genes Myh9 and Myh10, and quantitatively analyzed their development using time-lapse microscopy and immunostaining. The authors first examined the expression of NMHCs. Myh9 and Mhy10 are present in preimplantation embryos, and Myh9 is maternally inherited. Single maternal-zygotic mutants of Myh9 or Myh10 revealed that maternal Myh9 plays a major role in actomyosin contractility. In maternal Myh9 mutants, compaction and contractility at the 8-cell stage were reduced. Maternal Myh9 mutants demonstrated a longer 8-cell stage, and mutant blastocysts had reduced cell numbers. Cell positioning was not affected; however, cell differentiation was slightly affected by reduced expression of TE and ICM markers. Maternal Myh9 mutants formed blastocoels, but lumen opening was observed earlier than that in wild-type embryos. In double maternal-zygotic mutants of Myh9 and Myh10, cytokinesis was severely affected.
Nevertheless, TE fate was specified and embryos formed blastocoels. Interestingly, single-celled mutants swelled upon the formation of fluid-filled vacuoles in their cytoplasm. Similar TE fate specifications and cytoplasmic vacuoles were also observed with single-celled embryos produced by blastomere fusion. Based on these results, the authors concluded that maternal Myh9 is the major NMHC. However, Myh10 can significantly compensate for the loss of Myh9, and that cell fate specification and morphogenesis are independent of the success of cell division.
Overall, the conclusions of this study are supported by high-quality data. However, I have a few minor concerns:
We thank the referee for her/his careful analysis of our manuscript.
1. Line 200~205. The authors showed the correlation between the cell number at the blastocyst stage and the 8-cell stage, and concluded that "the lengthened 8-cell stage of mzMyh9 is an important determinant of their reduced cell number at the blastocyst stage". This conclusion is not well supported because of several reasons. First, the timing of cell count is not clear. Cell number was compared at the blastocyst stage, but Figure 1c shows that mzMyh9 embryos initiate blastocoel formation earlier than wild-type embryos. Therefore, if cell count timing was determined based on the blastocyst morphology of the embryos, the timing of cell count (i.e., time after 3rd cleavage) for mzMyh9 mutants is earlier than that observed for wild-type embryos. This shorter culture time likely contributes to the reduced cell number of mzMyh9. Second, the authors only showed a correlation, and no experimental data supporting this conclusion were shown. If the cell number was counted at the same time after the 3rd cleavage, and if the authors' hypothesis is correct, then culturing mzMyh9 mutants for an additional three hour, which is the difference in the duration of the 8-cell stage, should make the cell numbers of mutants comparable to those of wild-type blastocysts.
Although, this correlation provides the best explanation we had based on the data, we agree that the statement above is weakly supported by our study. We do not want to make a strong point about it since we do not think it brings much to the narrative of the study. We have removed the sentence.
2. Discussion. In the paragraph starting from line 405, the authors discussed the inconsistencies in the observation of the phenotypes of mzMyh9 and mzMyh10 mutants with the conclusions of previous studies by others about cell polarization. It will be informative to also discuss about inconsistency with their previous observations on cell fate. In their previous report (reference 8), the authors concluded that without contractile forces, blastomeres adopt an inner-cell-like fate regardless of their position. This is clearly opposite of the phenotype of mzMyh9;mzMyh10 mutants, in which all the cells are specified to TE. Please add a discussion addressing this discrepancy.
The data provided here are consistent with the ones from ref 8 (Maître et al., 2016): reduced contractility (Myh9 KO, double Myh9;Myh10 KO or Blebbistatin treatment) leads to reduced CDX2 levels. In ref 8, CDX2 and YAP are checked at the 16-cell stage, before the definitive differentiation into TE and ICM, whereas here we present data at the mid-blastocyst stage (~64 cells). We had not checked SOX2 in ref 8 since it is not expressed at such early stage, so we cannot conclude about this marker.
We want to clarify that, as stated in the manuscript, in mzMyh9;mzMyh10 KO we detect CDX2 in 5/7 embryos only and therefore not all cells are correctly specified into TE. However, SOX2 could be detected in the inner cell of the one embryo that produced an inner cell. We had not discussed this issue further since it is difficult to conclude much from such rare events and we would prefer to keep it as such.
To strengthen our argument about reduced differentiation in NMHC mutant embryos, we now provide YAP immunostaining (Figure S4). YAP is correctly patterned in Myh10 mutants and shows slightly less defined nuclear localization in Myh9 mutants, in agreement with our previous observations on CDX2 in the present study and previous observations on YAP at the 16-cell stage (Maître et al. 2016).
Together, we can conclude that, at the 16-cell stage, when ICM fate is not engaged yet (no detectable SOX2 expression), “inhibition of contractility causes (…) blastomeres to become inner-cell-like with respect to (…) Yap localization and Cdx2 levels, despite their external position” (Maître et al., 2016). At the blastocyst stage embryos with chronically impaired contractility can succeed in some but not all cases to produce TE (this study). Between these two developmental stages, blastomeres are exposed to prolonged signals from the apical domain and can be strongly deformed by the growing lumen. Based on the literature (Hirate et al. 2013, Dupont et al. 2011), both of these stimuli could potentially favor YAP nuclear localisation despite low contractility.
3. Throughout the paper, the description of gene and protein symbols should follow the rules of MGI's guidelines for nomenclature of genes (http://www.informatics.jax.org/mgihome/nomen/gene.shtml#gene_sym). Gene and allele symbols are italicized. Protein symbols use all uppercase letters and are not italicized.
We have corrected this.
4. Line 163. The term "contact angles" are used without any explanation or definition. The term should be introduced with a brief explanation in the text, preferably with a figure. It should help facilitate the understanding of the scientists working in different fields.
We have labelled a contact angle on Figure 1A and specified this in the text and in the figure legend.
Reviewer #1 (Significance (Required)):
The importance of actomyosin contractility in compaction, cell polarization, cell positioning, and cell fate specification in preimplantation embryos has been reported by several groups, mostly using chemical inhibitors, except for the study cited in reference 8, in which chimeras of wild-type and mMyh9 mutant embryos were used. This is the first genetic analysis of the roles of actomyosin contractility in the development of preimplantation embryos. Thus, the major advancement of this study is the genetic dissection of the roles of actomyosin contractility in preimplantation mouse development, and clarifying the contribution of maternal/zygotic Myh9 and Myh10 genes. While the phenotypes of reduced compaction and blastomere contractility are consistent with those observed in previous studies, polarization and TE fate specification of the mutant cells appear inconsistent with the conclusions of previous inhibitor experiments, which show defects in polarization processes and fate specification to ICM. These are potentially important issues, but detailed analyses were not performed. The requirement of actomyosin contractility for the cytokinesis of preimplantation embryos is also a novel finding, although it is expected from studies conducted in other systems. Vacuole formation in single-celled mzMyh9;mzMyh10 mutants in a timely manner suggested that fluid accumulation is a cell autonomous process and that cell differentiation occurs independently of cell division. These are also novel findings, although the latter is somewhat expected from previous studies performed using cell number manipulated embryos.
In summary, the conceptual advance offered by this study is small. However, this is a high-quality study and makes critical observations in the field of preimplantation mouse development. Scientists in the field of developmental biology, especially those working on preimplantation development, should be interested in this paper.
My field of expertise is preimplantation development.
We thank the reviewer for her/his appreciation of our work. We want to argue that we did perform a very detailed analysis of the development of the NMHC mutant embryos, with multiple quantitative image and data analyses to thoroughly and objectively characterise the phenotypes of these mutants. If by “detailed analysis”, the reviewer meant a molecular dissection of the phenotype, we argue that 1/ checking the end result (i.e. presence of TE and ICM markers, presence of polarised fluid transport) was sufficient to assess the functionality of biological processes without checking every steps of a signalling cascade; 2/ we now provide additional molecular information on the state of YAP and apico-basal polarisation (Figure S3-4).
Reviewer #2 (Evidence, reproducibility and clarity (Required)):
In this manuscript, Schliffka et al. report that maternally deposited Myh9 is the major NMHC in preimplantation embryonic morphogenesis and complete removal of both Myh9 and Myh10 caused severe cytokinesis failure similar to tissue culture cells. Interestingly, although the mutant embryos completely failed cytokinesis thus forming single-celled embryos, they initiated trophoblast gene expression and vacuolization (likely similar to blastocoel formation), suggesting that the timing of preimplantation developmental events is independent from cell number and morphogenetic events.
We thank the reviewer for her/his appreciation of our work.
Vacuolization in single-celled embryos is interesting. In the images, there looks to be two types of vacuoles, Factin positive and negative. The authors speculate the similarity to blastocoel formation. To support this, it is important to stain them with some basolateral markers like Na+ ATPase, E-cadherin and B-catenin. It is also important to confirm if the apical domain is properly formed by staining the apical domain markers like aPKC and Pard6.
We thank the reviewer for this suggestion. We now provide immunostaining of single Myh9 or Myh10 and double Myh9;Myh10 mutants for aPKC (PRKCz), Na/K ATPase (ATP1A1), Aquaporin-3 (AQP3), the best basolateral marker in our hands, which is also very relevant to fluid pumping, CDH1 and F-actin (Figure S3). We observe that these markers localise similarly in multiple-celled and single-celled embryos, suggesting that vacuoles de facto substitute for the basolateral compartment normally consisting of cell-cell contacts and the lumen. This suggests that the same machinery is at the origin of the fluid inside the lumen and inside vacuoles.
All gene names should be Italicized.
We have corrected this.
L157. Myh10 and Myh9 should be mMyh10 and mMyh9.
We have corrected this.
L294 1/8 embryos. What does this mean?
This means this was observed in 1 embryo out of 8 in total.
L333 6/25 embryos. Does this mean 6 out of 25 embryos combined all maternal double mutants?
L438-442. I do not find these embryos are similar to tetraploid embryos. I suggest to remove the sentences.
We have removed the sentences.
Reviewer #3 (Evidence, reproducibility and clarity (Required)):
This study investigates the roles of non-muscle myosin in development, reporting a requirement for maternal and zygotic Mhy9 and 10. Strengths of the study include robust genetic techniques, innovative nested imaging to visualize events over different timescales within the same embryos, and analysis of morphological as well as transcriptional/cell fate phenotypes. However, the somewhat superficial phenotype analysis limits the authors' ability to draw strong mechanistic conclusions about what is going on in these mutants. Is cell polarization normal? Is cell signaling (HIPPO signalling) normal?
We thank the reviewer for carefully assessing our study. We argue that we have thoroughly characterized the phenotypes of the NMHC mutants, which allowed us to draw many important mechanistic conclusions (such as the ability of NMHC mutants to polarise, or to pump fluid in a cell autonomous manner). Each mutant embryo has been imaged at multiple time scales, stained and genotyped. The time-lapses and immunostaining have been extensively quantified using manual as well as automated methods such as particle image velocimetry. We also provided fusion experiments, which phenocopy some aspects of the mutants to provide evidence of the mechanisms causing the observed phenotype.
Nevertheless, we agree that one can always do more and that we had focused on the biological processes (lineage specification, morphogenesis and cleavages) rather than molecular characterisation. Although polarised fluid pumping ascertains a functioning epithelial polarity, we now provide immunostaining of polarity markers in mutant embryos. Although CDX2 and SOX2 staining inform on the output of the signalling cascade leading to effective TE and ICM differentiation, we now provide YAP immunostaining of mutant embryos. We hope this satisfies the request from the reviewer.
What determines whether an embryo can form an inside cell or not?
This is an outstanding question. Cells can internalise by oriented cell division or contractility mediated cell sorting. Contractility-mediated internalisation functions with only 2 cells (as when doublets of 16-cell stage blastomeres form a cell-in-a-cell structure) but requires to grow above a tension asymmetry threshold (of 1.5 in WT and most likely above 3 in these mutants due to their poor compaction, see Maître et al. 2016). Oriented cell division only works if there is a cell-cell contact to push dividing cells in between. Therefore, at least 3 cells are required for an inner cell to be internalised by this mechanism.
In double mutants, the average cell number is 2.9. No embryo consisting of only 2 cells contained an inner cell, about half of embryos with 3-5 cells contained a single inner cell and all embryos with 6 cells or more contained inner cells (Figure 4D). Based on the low contractility of double mutants, we can speculate that they do not succeed in overcoming the tension asymmetry threshold. This would explain why no inner cell is observed in embryos with only 2 cells. We can speculate that with 3-5 cells, oriented divisions could occur thanks to the presence of functional polarity (Korotkevitch et al. 2017). We have added a discussion about this important matter.
Similarly, the manuscript would benefit from rewriting to reframe the authors' discoveries within the context of what is known regarding lineage specification (e.g., why does CDX2/SOX2 expression indicate normal lineage specification). Additional minor comments are listed below.
We elaborate on these points.
Introduction focuses overly on the work of the π and his mentor, giving the presentation an unnecessarily biased quality.
We have corrected this to the best of our ability. Please note that, to our knowledge, there are 8 studies (Anani et al., 2014; Maître et al., 2015; Samarage et al., 2015; Maître et al., 2016; Zhu et al., 2017; Zenker et al., 2018; Chan et al., 2019; Dumortier et al., 2019) looking in more or less details into the contractility of the preimplantation embryo. We mention and cite all of these studies.
The text asserts that Myh9 levels are highest during zygote stage, on the basis of qPCR (Figure S1A), and that this is also observed by RNA-seq (Figure S1B). However, this conclusion is not supported by the data shown.
We have corrected this.
Would be nice to repeat the qPCR on the mz null.
We agree with the referee that this would help in assessing the level of compensation between NMHC paralogs in individual mutants. Our qPCR protocol requires a few tens of embryos to be able to amplify the different paralogs.
Unfortunately, pooling embryos from our current mating strategy would result in pooling homozygote and heterozygote mutants as we cannot know a priori which embryo is of which genotype.
We believe that, as nice as this information would be, the current study does not require this information, which would be technically challenging.
Were the measurements shown in Figure S1F taken from the images shown in Figure S1E? If so, the authors should clarify how the measurements were normalized, since the images in Figure S1E were clearly taken with different camera settings (as judged by background fluorescence level surrounding the embryos).
The camera settings were identical but the LUT are set differently (to the maximal signal of a given genotype) so that some signal is visible. The signal intensities are so different between genotypes that if set to a common LUT, we either get the maternal GFP as a saturated white circle or the other genotypes as black images. We explain our LUT settings both in the methods and figure legends.
As an alternative to the current data presentation, we would be fine to have the same LUT for all images and show almost black images for WT and paternal GFP.
Can't really conclude that Myh9 is essential for compaction since compaction occurs (albeit abnormally) in the absence of Myh9 (line 177-178).
Our statement is “we conclude that maternal Myh9 is essential for embryos to compact fully”.
WT and mzMyh10 mutants increase their contact angles by 60° whereas mzMyh9 only grow by 30°. Double mutants compact less than single Myh9 mutants. Therefore, the compaction movement is halved in mzMyh9 and the residual weak compaction could be explained by compensation from Myh10. We stand by our statement.
ine 211: "observe" rather than "measure".
We have corrected this.
If the embryos achieve proper ICM/TE ratio, in spite of having half the number of cells in the mutants, is that to be expected? Would/do halved embryos also possess the same ICM/TE ratio? Or is this outcome peculiar to the mutants?
This is an interesting question on which we had not sufficiently elaborated. Our experiments with cell fusion at the 4-cell-stage (Figure S5) produced embryos with reduced cell number. These resemble Myh9 mutant embryos in the aspect that they show a reduced cell number while maintaining the total embryonic cell mass. In both cases, the ICM/total cell ratio is similar to control embryos. This indicates a robust mechanism of ICM/TE ratio setting that is robust to the cell number change observed in the single mutant. We have added a discussion about this.
Line 222: what is the evidence that Cdx2 and Sox2 are TE and ICM markers?
We have added references to the studies from Strumpf et al., 2005 and Avilion et al., 2003 to support these claims.
Is the reported reduction in CDX2 and SOX2 levels due to a stage-delay? What would the comparison look like in wt embryos with half as many cells? Timing of lumen formation may or may not indicate developmental timing…
We address this point by fusing embryos to half the cell number and find that the fate marker levels are specifically affected as a result of mutation of Myh9 (Figure S5).
We agree that the timing of lumen formation is unlikely to be a good reference for staging and we did not use this event. We do synchronise embryos based on lumen opening only when comparing lumen growth rate.
Line 240 – what was the correction on the multiple pairwise comparisons (multiple t tests)?
To compare lumen growth rate, individual growth rates of mutants are compared to those of WT using Student’s t test. Growth rates are considered as normally distributed and independent (not pairwise).
Lumen forms on time in mutants, despite having fewer cells. Alternatively, lumen forms early, prior to acquisition of proper cell number. Is there a reason the authors did not consider this alternative?
The referee is correct. Lumens form with fewer cells in mutant embryos and therefore prior to the acquisition of proper cell number.
Lines 306 and 339: why does lack of SOX2 expression suggest that the lineage specification program is intact?
Why does expression of CDX2 suggest TE initiation has occurred normally? The regulation of these two markers was not introduced.
We have better introduced and justified this aspect.
Line 349: why is blastocoel formation a cell-autonomous property when it clearly occurs extracellularly? Does this also happen in wild type embryos?
Blastocoel formation is clearly a multi-cellular process. We argue that fluid accumulation is not. The implications for WT embryos are that fluid can be accumulated in the blastocoel entirely trans-cellularly (no need for fluid to flow through cell-cell junction).
Speculate in Discussion on why the ML-7/Blebbistatin experiments results could differ from the genetic results produced here.
Blebbistatin experiments are in agreement with the mutant data. ML-7 experiments are partially in agreement with the mutant data. The discrepancy lies in the effect on cell polarity. ML-7 affects kinases other than the MLCK, such as PKC, which is a known regulator of cell polarity during preimplantation development. Although this is speculative, we specify this in the revised manuscript.
Can these mutant embryos implant?
We grow colonies of heterozygous mutants, therefore mMyh9, mMyh10 and mMyh9;mMyh10 embryos are viable and must be able to implant. As for homozygous mutants, they are not viable and we do not know whether they can implant.
Reviewer #3 (Significance (Required)):
The study provides the first strong evidence of a requirement for non-muscle myosin in epithelialization. This is significant to embryology and to epithelial biology.
We thank the reviewer for appreciating the significance of our study. We want to clarify that our study provides evidence for NMHC as NOT being required for de novo epithelialization.https://doi.org/10.7554/eLife.68536.sa2
- Markus Frederik Schliffka
- Özge Özgüç
- Özge Özgüç
- Jean-Léon Maître
- Jean-Léon Maître
- Jean-Léon Maître
- Jean-Léon Maître
- Jean-Léon Maître
- Jean-Léon Maître
- Jean-Léon Maître
- Jean-Léon Maître
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
We thank the imaging platform of the Genetics and Developmental Biology unit at the Institut Curie (PICT-IBiSA@BDD), member of the French National Research Infrastructure France-BioImaging (ANR-10-INBS-04) for their outstanding support; the animal facility of the Institut Curie for their invaluable help. We thank Aurélie Teissendier for help with bioinformatic analysis, Victoire Cachoux for help with image analysis, and Yohanns Bellaïche for discussion and advice on the manuscript. Research in the lab of J-LM is supported by the Institut Curie, the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Santé Et de la Recherche Médicale (INSERM), and is funded by grants from the ATIP-Avenir program, the Fondation Schlumberger pour l’Éducation et la Recherche via the Fondation pour la Recherche Médicale, the European Research Council Starting Grant ERC-2017-StG 757557, the European Molecular Biology Organization Young Investigator program (EMBO YIP), the INSERM transversal program Human Development Cell Atlas (HuDeCA), Paris Sciences Lettres (PSL) ‘nouvelle équipe’ and QLife (17-CONV-0005) grants and Labex DEEP (ANR-11-LABX-0044), which are part of the IDEX PSL (ANR-10-IDEX-0001–02). MFS is funded by a Convention Industrielle de Formation pour la Recherche (No 2019/0253) between the Agence Nationale de la Recherche and Carl Zeiss SAS. ÖÖ is funded from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 666003 and benefits from the EMBO YIP bridging fund.
Animal experimentation: All animal work is performed in the animal facility at the Institut Curie, with permission by the institutional veterinarian overseeing the operation (APAFIS #11054- 2017082914226001). The animal facilities are operated according to international animal welfare rules.
- Edward E Morrisey, University of Pennsylvania, United States
© 2021, Schliffka et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.